Skip to main content
Equibles

Elmind Capital, LP

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 2052213 NEW YORK, NY
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,255,700
+$2,221,900 QoQ
Shares Held
70,000
+250.0% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#81
of 335 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Elmind Capital, LP holds $18,594,670 across 4 Drug Manufacturers - Specialty & Generic names. SUPN ranks #3 (17.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 15,000 $8,127,450
2 BCRX
Biocryst Pharmaceuticals Inc
 520,000 $5,200,000
3 SUPN
Supernus Pharmaceuticals, Inc.
This page 		70,000 $3,255,700
4 AMLX
Amylyx Pharmaceuticals, Inc.
 112,000 $2,011,520

All Filings in SUPN

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,255,700 70,000
2026-03-31 $1,033,800 20,000
2025-12-31 $994,000 20,000